Tandem Diabetes Care, Inc. (TNDM) Free cash flow 2016–2025
Tandem Diabetes Care, Inc. (TNDM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$29.7MFY2025 · since FY2016: -$70.1M → -$29.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.7M | -694.1% |
| FY2024 | $5.0M | +108.5% |
| FY2023 | -$58.6M | -458.1% |
| FY2022 | $16.4M | -83.2% |
| FY2021 | $97.2M | +3648.0% |
| FY2020 | -$2.7M | -112.2% |
| FY2019 | $22.4M | +297.8% |
| FY2018 | -$11.3M | +84.3% |
| FY2017 | -$71.9M | -2.5% |
| FY2016 | -$70.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice